Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ONO-4685 by Ono Pharmaceutical for Follicular Lymphoma: Likelihood of Approval
ONO-4685 is under clinical development by Ono Pharmaceutical and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...